|
|
Main Program
| MainHall, Friday, October 6, 2006, 10:00 |
| Novartis Symposium - Angiotensin-II Blockade in Cardiovascular Continuum |
Moderator: P. M. Seferović
10:00 Introduction
P. M. SEFEROVIĆ, Belgrade, RS
10:05 RAS blockade as a fundamental principle in contemporary
therapy of hypertension.
S. DIMKOVIĆ, Belgrade, RS
10:25 Angiotensin - II blockade with valsartan - proven efficacy in
cardiovascular continuum.
P. M. SEFEROVIĆ, Belgrade, RS
10:45 Discussion
Not accredited by EBAC |
| MainHall, Friday, October 6, 2006, 11:30 |
| Epidemiology and Pathophysiology |
Chairpersons: L. Tavazzi, S.I. Nedeljković, A. Milošević, Lj. Perović, B. Knežević
11:30 Epidemiology and classification of myocardial and pericardial diseases: unsolved issues.
P.M. SEFEROVIĆ, Belgrade, RS
11:50 Virus persistence as a determinant for disease progression in inflammatory cardiomyopathy.
A. KEREN, Jerusalem, IL
12:10 The role of natriuretic peptides in pathophysiology of left ventricular dysfunction: focus on urodilatin.
M. MEYER, Hannover, DE
12:30 Increasing role of myocardial diseases in heart failure: Urge for clinical trials & cardiomyopathy units.
L. TAVAZZI, Pavia, IT
12:50 Discussion |
| MainHall, Friday, October 6, 2006, 13:30 |
| European Cardiopathology Forum 2006 |
Chairpersons: V. Kanjuh, E. Arbustini, G. Thiene, U. Baandrup, Z. Marsenić
13:30 KEY-NOTE CARDIOPATHOLOGY LECTURE
"Torrent-Guasap's heart" (helical ventricular myocardial band): morphology and clinical implications.
V. KANJUH, Belgrade, RS |
| Quo Vadis Endomyo-pericardiak biopsy? |
13:50 Genetic predisposition and differential gene expression in myocardial disease and heart failure: clinicopathological correlations
E. ARBUSTINI, Pavia, IT
14:10 Histopathology and molecular biology of inflammatory myocardial disease.
G. THIENE, Padua, IT
14:30 The fate of two sisters: clinical relevance of endomyocardial and pericardial biopsy.
U. BAANRUP, Aarhus, DK
15:00 KEY-NOTE CLINICAL LECTURE (Introduction by G. THIENE)
Optimal therapy for chronic heart failure: from the guidelines to bedside.
K. SWEDBERG, Gothenburg, SE
15:20 Discussion |
| MainHall, Friday, October 6, 2006, 15:45 |
| Hemofarm Cardiology Symposium - ACE Inhibition as a Cornerstone of the Prevention and Treatment of Complex Cardiovascular Diseases |
15:45 Introduction - ACE inhibition: only true blockade of neurohumoral
activation.
P.M. SEFEROVIĆ, Belgrade, RS
15:50 Rationale, background, and efficacy of ACE inhibition in arterial
hypertension and heart failure: ischemic heart and cerebrovacular
disease can be prevented.
V. MITROVIĆ, Bad Nauheim, DE
16:10 High efficacy, low side-effects and improved cardiovascular
outcomes of ACE inhibition in heart failure and coronary artery
disease: neurohumoral, clinical, and hemodynamic advantages.
P.M. SEFEROVIĆ, Belgrade, RS
16:30 Discussion
Not accredited by EBAC |
| MainHall, Friday, October 6, 2006, 17:30 |
| State-Of-The-Art In Diagnostic Assessment: Advances Through Technology |
Chairpersons: M. Tendera, L. Padeletti, S. Ilić Z. Mijailović, R. Maksimović
17:30 Multiparametric analysis of ECG & arrhythmias in dilated cardiomyopathy & myocardial inflammation.
G. GENSINI, Florence, IT
17:50 Echocardiography in myocardial disease: from gold-standard basic assessment to sophisticated applications.
B. VUJISIĆ-TEŠIĆ, Belgrade, RS
18:10 CT and MRI: powerful tools to enhance the diagnostic spectrum?
R. MAKSIMOVIĆ, Belgrade, RS
18:30 Viral disease of the heart and pericardium: PCR as the milestone in contemporary diagnostics and research.
S. PANKUWEIT, Marburg, DE
18:50 Discussion |
| MainHall, Friday, October 6, 2006, 19:00 |
| Clinical Trials Hot Line Lecture |
(Introduction by M. Tendera)
19:00 Cornerstones of heart failure management: updates from major clinical trials.
K. DICKSTEIN, Stavanger, NO
19:20 Discusion |
|
|
|
 |
